NovaBridge Biosciences (NBP) Gross margin 2021–2022
NovaBridge Biosciences (NBP) gross margin by fiscal year — reported gross profit divided by reported revenue.
98.3%FY2022 · since FY2021: -69.1% → 98.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 98.3% | +167.4 pp |
| FY2021 | -69.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice